Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cesano

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|June 8, 2012
Racial differences in B cell receptor signaling pathway activationDiane M Longo, Brent Louie, Kavita Mathi, et al.
Journal for Immunotherapy of Cancer|June 23, 2018
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteersParnian Zia-Amirhosseini, Margaret Salfi, Philip Leese, et al.
Plos One|September 3, 2010
Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemiaDavid B Rosen, Santosh Putta, Todd Covey, et al.
Journal of Translational Medicine|June 27, 2014
Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP)David B Rosen, Ling Y Leung, Brent Louie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingPatrick J Stiff, Christos Emmanouilides, William I Bensinger, et al.
Plos One|November 5, 2010
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP)David B Rosen, Mark D Minden, Steven M Kornblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapyLee S Rosen, Ehtesham Abdi, Ian D Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapySteven M Kornblau, Mark D Minden, David B Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancerJohn R Zalcberg, Lee S Rosen, Ehtesham Abdi, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|June 8, 2012
Racial differences in B cell receptor signaling pathway activationDiane M Longo, Brent Louie, Kavita Mathi, et al.
Journal for Immunotherapy of Cancer|June 23, 2018
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteersParnian Zia-Amirhosseini, Margaret Salfi, Philip Leese, et al.
Plos One|September 3, 2010
Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemiaDavid B Rosen, Santosh Putta, Todd Covey, et al.
Journal of Translational Medicine|June 27, 2014
Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP)David B Rosen, Ling Y Leung, Brent Louie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingPatrick J Stiff, Christos Emmanouilides, William I Bensinger, et al.
Plos One|November 5, 2010
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP)David B Rosen, Mark D Minden, Steven M Kornblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapyLee S Rosen, Ehtesham Abdi, Ian D Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapySteven M Kornblau, Mark D Minden, David B Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancerJohn R Zalcberg, Lee S Rosen, Ehtesham Abdi, et al.
Pageof 9